DOFETILIDE
Generic: DOFETILIDE
Dr. Reddy's Labratories Inc.Manufacturer
ORALRoute
DOFETILIDEActive Substance
2016-06-06Original Approval
DOFETILIDE is FDA application ANDA207058, sponsored by DR REDDYS LABS SA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2023-02-07
Dofetilide Capsules 250 mcg (0.25 mg) 60-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27CGMP Deviations: recalling drug products following an FDA inspection.
Class III2023-07-18
Dofetilide Capsules 500 mcg (0.5mg), 60-count bottle, Rx Only, Manufactured by Sun Pharmaceutical Industries Limited, SuOut of Specification result observed in content uniformity testing
Class II2023-02-07
Dofetilide Capsules 500 mcg (0.5 mg), 60-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27CGMP Deviations: recalling drug products following an FDA inspection.
Class II2023-02-07
Dofetilide Capsules, 125 mcg (0.125 mg), 60-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NCCGMP Deviations: recalling drug products following an FDA inspection.
Top Reported Reactions
1
DRUG INEFFECTIVE
341 reports
2
ATRIAL FIBRILLATION
218 reports
3
DEATH
171 reports
4
ELECTROCARDIOGRAM QT PROLONGED
168 reports
5
DYSPNOEA
162 reports
6
DIZZINESS
126 reports
7
FATIGUE
126 reports
8
DIARRHOEA
91 reports
9
HEADACHE
91 reports
10
TORSADE DE POINTES
80 reports